Titan Pharmaceuticals
TTNP
#10775
Rank
HK$48.09 M
Marketcap
HK$36.15
Share price
-3.76%
Change (1 day)
16.01%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -HK$34.26

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -HK$34.43. In 2023 the company made an earnings per share (EPS) of -HK$58.11 an increase over its 2022 EPS that were of -HK$119.12.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$34.26
2023-HK$58.11-51.22%
2022-HK$119.12-15.61%
2021-HK$141.16-81.37%
2020-HK$757.56-77.52%
2019-HK$3,371-56.32%
2018-HK$7,717-59.51%
2017-HK$19,061-371.81%
2016HK$7,012-144.35%
2015-HK$15,810300%
2014-HK$3,953-121.54%
2013HK$18,351-151.38%
2012-HK$35,714-11.54%
2011-HK$40,372188.89%
2010-HK$13,975-10%
2009-HK$15,528
2007-HK$63,664-2.38%
2006-HK$65,216-39.13%
2005-HK$107,141-16.87%
2004-HK$128,880-22.43%
2003-HK$166,1464.9%
2002-HK$158,38261.9%
2001-HK$97,824-13.7%
2000-HK$113,35265.01%
1999-HK$68,695-35.87%
1998-HK$107,123-1824.71%
1997HK$6,211-102.4%
1996-HK$259,313

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.51-299.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$55.05-259.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-HK$11.14-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
HK$7.21-120.96%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-HK$1.96-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$30.51-11.39%๐Ÿ‡บ๐Ÿ‡ธ USA